Entrepreneur ranking retracted for not being “inclusive enough”

VENTUREBURN_HIRES_logo

This is a first for us — a publication that covers start-ups in South Africa has retracted a list of 13 rising tech entrepreneurs for not being “inclusive enough.”

Lists are a staple of popular media, so much so that they’ve earned their own word: listicle. But we’ve never seen one get retracted before. We weren’t sure what metric of inclusion the retraction was referring to, but looking at an archive of the webpage, where the listicle appeared before the publication was taken down, we saw that every person on the list appears to be a man, and almost all of them white.

We asked Stuart Thomas, Senior Reporter at Memeburn — which published the list with a related publication, Ventureburn — if this was what the publication meant by not “inclusive enough:”

It was a factor, yes.

Here’s the note for “Digital All Stars 2015: 13 South African tech entrepreneurs on the rise:”  Continue reading Entrepreneur ranking retracted for not being “inclusive enough”

Authors retract second study about medical uses of honey

Journal of Clinical NursingA paper that tested the clinical value of honey on venous ulcers has been pulled by the Journal of Clinical Nursing after an investigation uncovered “errors in the data analysis.” Last year, the authors pulled another paper on the healing properties of honey on wounds. 

We just discovered this second retraction, which appears in the September 2015 issue of the journal, but was posted online last year.

The journal’s editor-in-chief, Debra Jackson, confirmed the dates and said that “a commercial company” brought the matter to their attention. After the journal asked a statistician to weigh in, they stated that a “substantial re-write would be required to correct the article,” and a retraction would be “the most suitable course of action.”

Although she said the authors initially sought to correct, not retract, the study, they eventually agreed with the decision.

Here’s the notice:

Continue reading Authors retract second study about medical uses of honey

Serial plagiarist’s retractions upped to 14

We’ve done some digging, run the numbers, and present to you a new member of our leaderbcov200hoard: orthopedic researcher Bernardino Saccomanni. Nine newly unearthed retractions of his make for a total of 14.

We first reported on Saccomanni’s work back in 2011, and identified him as a “serial plagiarist.” In the years since, he’s continued to rack up retractions for papers on the likes of ligament reconstruction and shoulder pain. On every paper, he is listed as the sole author.

Bernardino Saccomanni’s most recently listed affiliation on the papers is “Ambulatorio di Ortopedia, via della Conciliazione.” He sometimes also lists his affiliation as Gabriele D’ Annunzio University Chieti, even though, as we learned a few years ago, he hasn’t worked there for many years.

There’s a lot to cover here, so stick with us:

1) First up, “A new test for acromio-clavicolar pathology” was published in the Journal of Clinical Orthopedics and Trauma and cited zero times according to Thomson Scientific’s Web of Knowledge. Here’s the retraction note:

Continue reading Serial plagiarist’s retractions upped to 14

Diederik Stapel retraction count updated to 57

stapel_npcWe’ve learned about two more retractions we missed for Diederick Stapel, the Dutch social psychology researcher who has now racked up a total of 57 retractions by our count.

Both retractions were issued after a committee released a report which established fraud in dozens of papers co-authored by Stapel.

Stapel is still #4 on our leaderboard.

Continue reading Diederik Stapel retraction count updated to 57

Defamation concerns prompt theology journal to pull paper

HTS Teologiese Studies:Theological StudiesThe editor-in-chief of a theology journal has retracted a paper on South African Christian groups because of “unsubstantiated statements with potential defamation of character.”

The article, published in 2007 in HTS Teologiese Studies/Theological Studies, discusses “demanding Christian religious movements” where the group “isolates itself from the outside world,” and leaders influence their followers to “commit to the high demands of the group under the guise that this is the will and purpose of God,” according to the paper.

The author calls out several groups and leaders by name:

Continue reading Defamation concerns prompt theology journal to pull paper

Prostate cancer paper flagged by ORI is retracted following PETA prompt

cover_issue_129_en_USA federal investigation into a paper on prostate cancer has now led to a retraction. In an unusual twist, it happened following a request from the animal rights group People for the Ethical Treatment of Animals (PETA).

In January, the Office of Research Integrity reported that corresponding author Dong Xiao “intentionally fabricated data” in an Oncotarget study of how a steroid inhibits the growth of prostate cancer. Xiao, a former cancer researcher at the University of Pittsburgh, claimed that he had tumor data from more mice than he did, and falsified several figures.

In July, after no sign of the retraction, a researcher at PETA followed up with the journal, Oncotarget, on behalf of the organization “and our more than 3 million members and supporters to request the immediate retraction.”

Last month, they received a reply from the publisher, which they forwarded to us:

Continue reading Prostate cancer paper flagged by ORI is retracted following PETA prompt

Mega-correction for “empirical anomalies” in management paper

The Academy of Management JournalThe author of a paper that looked at how the geographical spread of research and development sites has impacted innovation has posted a four-page list of corrections that fixed “empirical anomalies” in the paper.

A group of PhD students raised concerns about the paper’s findings, according to the editor-in-chief of The Academy of Management Journal, Gerard George. The journal formed a committee that worked with the author to reproduce the results. That ended with a correction to two of the paper’s three hypotheses, and corresponding parts of the text.

The four-page notice — (the details of which are paywalled, unfortunately) — includes notes from the journal’s editor and the author:

Continue reading Mega-correction for “empirical anomalies” in management paper

Weekend reads: Angry meta-analysts; imposter cell lines; when things go wrong

booksThis week at Retraction Watch featured nine more fake peer review retractions, this time from Elsevier, and an update to the retraction count for one-time record holder Joachim Boldt. Here’s what was happening elsewhere: Continue reading Weekend reads: Angry meta-analysts; imposter cell lines; when things go wrong

Former ob-gyn prof notches ninth retraction; investigation still underway

Nasser Chegini
Nasser Chegini

A retired obstetrics and gynecology professor under federal investigation for misconduct has notched his ninth retraction.

The latest retraction stems from an investigation by the University of Florida, where Nasser Chegini worked until 2012, which found fabricated data in three figures in a paper on the muscle cells that line the uterus.

The paper, “Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids,” was published in The Journal of Cellular and Molecular Medicine. It’s been cited 74 times, according to Thomson Scientific’s Web of Knowledge.

Here’s the note:

Continue reading Former ob-gyn prof notches ninth retraction; investigation still underway

“Insufficient permission” from funder resects liver disease paper

HepatologyA study on chronic liver inflammation was pulled from the journal Hepatology because of “insufficient permission by the authors’ funding institution to submit and publish the manuscript.” 

The paper, which was published in July, looked into how steatosis, the abnormal retention of fat in the liver, turns into steatohepatitis, also known as fatty liver disease. Researchers found that Treg cells play a central role in controlling the disease.

Unfortunately, the journal’s managing editor didn’t provide any information about the nature of the permission problems, and the notice doesn’t give any details.

Here it is, in full:

Continue reading “Insufficient permission” from funder resects liver disease paper